APOB and metabolic dysfunction-associated steatotic liver disease: In a large prospective study involving 1139 participants, Wang et al. found that increased APOB levels (>1.17 g/dL) were independently associated with NAFLD in multivariable models adjusted for patient demographics and clinical and biochemical variables (OR 1.631, 95% CI, 1.17–2.26, p = 0.001) [227].